ABBOTT LABORATORIES Stockholders Equity

• ABBOTT LABORATORIES showed an increase of +9.4% in Stockholders Equity from 2024 to 2025.
• This data is from ABBOTT LABORATORIES's annual report (Form 10-K), filed with the SEC on February 20, 2026.
• XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2009: $19.88 billion | Q3 2009: $21.34 billion | Q1 2010: $20.86 billion | Q2 2010: $19.91 billion | Q3 2010: $21.40 billion | Q1 2011: $24.63 billion | Q2 2011: $26.38 billion | Q3 2011: $24.60 billion | Q1 2012: $25.45 billion | Q2 2012: $24.49 billion | Q3 2012: $27.01 billion | Q1 2013: $22.59 billion | Q2 2013: $22.34 billion | Q3 2013: $23.70 billion | Q1 2014: $23.39 billion | Q2 2014: $23.60 billion | Q3 2014: $22.89 billion | Q1 2015: $21.87 billion | Q2 2015: $23.01 billion | Q3 2015: $21.11 billion | Q1 2016: $20.72 billion | Q2 2016: $20.68 billion | Q3 2016: $20.78 billion | Q1 2017: $31.36 billion | Q2 2017: $31.60 billion | Q3 2017: $32.03 billion | Q1 2018: $31.40 billion | Q2 2018: $30.58 billion | Q3 2018: $30.71 billion | Q1 2019: $30.93 billion | Q2 2019: $31.69 billion | Q3 2019: $31.82 billion | Q1 2020: $30.22 billion | Q2 2020: $30.58 billion | Q3 2020: $31.39 billion | Q1 2021: $33.56 billion | Q2 2021: $33.80 billion | Q3 2021: $34.42 billion | Q1 2022: $35.40 billion | Q2 2022: $36.49 billion | Q3 2022: $35.68 billion | Q1 2023: $37.01 billion | Q2 2023: $37.17 billion | Q3 2023: $37.48 billion | Q1 2024: $38.81 billion | Q2 2024: $39.32 billion | Q3 2024: $39.80 billion | Q1 2025: $48.81 billion | Q2 2025: $50.57 billion | Q3 2025: $50.95 billion.
• Over the full 19 years of available data (2007 to 2025), ABBOTT LABORATORIES's Stockholders Equity has grown by 193.2%.
• Historical annual values: Fiscal year 2025: $52.13 billion | Fiscal year 2024: $47.66 billion | Fiscal year 2023: $38.60 billion | Fiscal year 2022: $36.69 billion | Fiscal year 2021: $35.80 billion | Fiscal year 2020: $32.78 billion | Fiscal year 2019: $31.09 billion | Fiscal year 2018: $30.52 billion | Fiscal year 2017: $30.90 billion | Fiscal year 2016: $20.54 billion | Fiscal year 2015: $21.21 billion | Fiscal year 2014: $21.53 billion | Fiscal year 2013: $25.17 billion | Fiscal year 2012: $26.72 billion | Fiscal year 2011: $24.44 billion | Fiscal year 2010: $22.68 billion | Fiscal year 2009: $23.14 billion | Fiscal year 2008: $17.48 billion | Fiscal year 2007: $17.78 billion.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026